However, we take Daxi’s 6-month claim with a pinch of salt because it’s been provided by the drug’s manufacturer. Daxi’s freshly FDA approved, so it’s not in medical offices just yet. So, the only data we have relies on Revance Therapeutics‘ clinical trials. Those results showed patients had a 6-month median duration in results, with some even maintaining treatment results until 9 months. Sounds promising, but we’ll have a better concept of results — the pros and cons as compared to other injectable options — once doctors start injecting their Botox users with Daxi and seeing their results.